XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.80

-0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (5002)	12/5/1997 2:25:00 AM
From: Eric Klein	Read Replies (1) of 17367

If BPI is ever approved ...would it not be given at almost the same time as an antibiotic? This is one of the most IMO exciting things about BPI, i.e. when given with an antibiotic (antibiotic adjuvant) it can increase the effectiveness of the antibiotic. It thus makes existing antibiotics more effective. To my mind this is the real gold mine. If every dose of antibiotics includes a dose of BPI, then XOMA could do very well.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next